Mortality risk in patients with myasthenia gravis by Mohamed Khateb, Mohamed Khateb, Shahar Shelly, Shahar Shelly, Shahar Shelly

Get full text

Malignancy in neuromuscular patients on chronic IVIG by Mohamed Khateb, Elian Bahous, Mai Abu Zant, Shahar Shelly, Shahar Shelly, Shahar Shelly

Get full text

Mobile application leads to psychological improvement and correlated neuroimmune function change in subjective cognitive decline by Merav Catalogna, Nira Saporta, Bar Nathansohn-Levi, Tal Tamir, Ariel Shahaf, Shira Molcho, Shai Erlich, Shahar Shelly, Amir Amedi

Get full text

Brain connectivity correlates of the impact of a digital intervention for individuals with subjective cognitive decline on depression and IL-18 by Merav Catalogna, Ya’ira Somerville, Nira Saporta, Bar Nathansohn-Levi, Shahar Shelly, Liat Edry, Orna Zagoory-Sharon, Ruth Feldman, Amir Amedi

Get full text

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel by Shahar Shelly, Marc Gotkine, Adi Wilf Yarkoni, Itay Lotan, Alon Abraham, Amir Dori, Gil I. Wolfe, Keren Regev, Adi Vaknin, Tamir Ben-Hur

Get full text